Trial Profile
Efficacy and safety of long-term therapy of vedolizumab in inflammatory bowel disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2017
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 23 Oct 2017 New trial record